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The development of a convenient mathematical application for testing the antioxidant potential of standard and novel therapeutic
agents is essential for the research community to perform evaluations in a more precise form. The in vitro oxidative hemolysis
inhibition assay, despite its relevance for in vivo responses, lacks a proper mathematical model to quantify the responses. In this
work, a simple nonlinear time-dose tool to test the effectiveness of antioxidant compounds is presented.Themodel was verifiedwith
available experimental data from the bibliography.Themodel helps to describe accurately the antioxidant response as a function of
time and dose allowing comparisons between compounds. Its advantages are a simple application, provision of parametric estimates
that characterize the response, simplification of the protocol, economization of experimental effort, and facilitation of rigorous
comparisons among the effects of different compounds and experimental approaches. Finally, other effectors that may obstruct or
be of interest for the antioxidant determination are alsomodeled in similar principles.Thus, the basis ofmore complexmultivariable
models is provided. In all experimental data fitted, the calculated parameterswere always statistically significant, the equations prove
to be consistent, and the correlation coefficient of determination was in all cases higher than 0.98.
1. Introduction
Antioxidants (A) and prooxidants are chemical entities that
can delay or accelerate oxidation processes. Living organisms
have developed a complex network [1, 2] of enzymatic and
nonenzymatic A, which are essential to counteract various
harmful prooxidants or reactive species (i.e., O
2
, H
2
O
2
,
ROO∙, and OH∙) [3, 4]. Apart from these endogenous A,
exogenous ones can derive from natural sources (vitamins,
flavonoids, anthocyanins, and some mineral compounds).
Clinical trials and epidemiological studies have established an
inverse correlation between the intake of natural exogenous
A and the occurrence of oxidative stress diseases such as
inflammation, cardiovascular problems, cancer, and aging-
related disorders [5–7]. Thus, the analysis of natural antioxi-
dants for disease prevention and the identification of possible
prooxidant substances have become topics of growing interest
[8–10].
Several in vivo and in vitromethods have been developed
for determining the A properties of compounds in order
to rank their affinity. In general, these assays differ in their
mechanism to generate different radical species and/or target
molecules and in the way end-products are measured. At
present, there is no convenient assay that enables the evalua-
tion of the antioxidant capacity (AC) for different compounds
[5, 11, 12]. The current methods to test the AC still have left
many open questions [13, 14].The in vitro assays can only rank
AC for their particular reaction system and their relevance to
in vivo activities is uncertain.Thus, it is logical that, in the last
decade, researchers have claimed more cell based approaches
[5, 15–17]. Additionally, the arbitrary use of simple analytical
procedures to calculate molecular properties, occasionally
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without a validation study, as well as a lack of statistical
significance, has caused much controversy [18–23].
OxHLIA is a bioassay for evaluating the inhibition
capabilities of A [24], half way between in vivo and in
vitro methods. Sheep erythrocytes are subjected to hemol-
ysis by the action of hydrophilic and lipophilic radicals in
aqueous system. Hydrophilic radicals are generated from
the thermal decomposition of AAPH (2,20-azobis(2-methyl-
propionamidine) dihydrochloride) attacking the erythro-
cytes membranes. Lipophilic radicals are derived from the
oxidation of the erythrocytes membranes (lipid peroxi-
dation), a phenomena that is initiated by the action of
AAPH and thermal induction.The lipophilic and hydrophilic
radicals eventually cause the hemolysis of the cell. The
time at which the hemolysis occurs depends on the resis-
tance of the erythrocytes population. This hemolytic time
can be retarded by antioxidants, capturing the hydrophilic
and/or lipophilic radicals. The advantages of OxHLIA are
that radicals and substrate targets are biologically relevant
compared to other in vitro methods and that antioxidants
are subjected to oxidants with different degrees of polarity
[25].
Originally, the OxHLIA was performed in a test-tube
format, and the degree of hemolysis was spectrometrically
determined in the supernatant after centrifugation [24].
Those steps impeded researchers to test large numbers of
samples at the same time. Since the development of the
method, several studies have improved and extended the
applicability of the method [26–29]. Recently, authors [30]
have performed a further key modification, which allows
following the degree of hemolysis via turbidity of the erythro-
cyte suspension without centrifugation. This improvement
enhances the applicability of OxHLIA into a microplate
format. The method thus performed enables evaluation of
large numbers of samples of small quantity at the same time
with satisfactory precision and reproducibility and in an
equivalent way to the previous format procedures.
Its main weakness is the insufficient formalism due to
the lack of formal model to describe the kinetic erythrocyte
hemolysis, which prevents the quantification of its statistical
reliability and loses a part of the relevant information that
can be drawn from the experimental results. Therefore, the
quantification relies on graphical, or similar methodologies,
which causes low reproducibility of the results and leads to an
accumulation of procedural restrictions that overstandardize
the protocol [31]. Although the meticulous results can be
found concerning the kinetics and the factors affecting the
reproducibility of themethod, the quantification of the results
has been left as it was postulated originally [24].
In the current study, a nonlinear mathematical appli-
cation for describing the OxHLIA responses is developed.
It helps to describe accurately the response as a function
of time and dose, to provide parameters that summarize
the responses, and to facilitate convenient comparisons of
the AC of different compounds. In addition, by analyzing
the data of other authors that have studied the effects
of other variables or agents over the kinetic erythrocyte
population curve, more complex analysis for AC of antiox-
idants is suggested. Therefore, the basis for postulating more
complex multivariable models is also provided. Because the
available methodological studies of the OxHLIA appear to
have reviewed and extended its procedure into a robust
methodology, no improvements of the protocol have been
performed.
2. Material and Methods
2.1. The OxHLIA Procedure. As recommended by Take-
bayashi et al. [32], erythrocytes need to be obtained from
several adult sheep to reduce the influence of individual
differences. Although the common procedure uses sheep ery-
throcytes, other sources such as human or bovine ones have
been proved to produce similar results. Erythrocytes should
be washed at least three times with PBS and resuspended in
PBS at a 2.8% (v/v) suspension.
2.1.1. Test-Tube Format. Asdescribed [32], sheep erythrocytes
are suspended at a final concentration inwhich themaximum
hemoglobin liberated cannot saturate the spectrophotometer
measuring.The solution is prepared in 0.7% (v/v) phosphate-
buffered saline (PBS, pH 7.4) with ∼40mM of AAPH in the
absence (control) and presence of increasing concentrations
of antioxidant sample in a test tube at 37∘C in a water bath
with shaking. An aliquot of this mixture was periodically
withdrawn every 15min for 3 h, and the degree of hemolysis
(%) was determined from the concentration of hemoglobin
in the supernatant after centrifugation by measuring the
absorbance at 524 nm. The results are expressed as delayed
time of hemolysis (Δt) as follows:
Δ𝑡 = 𝜏
𝑆
− 𝜏
𝐶
, (1)
where 𝜏 is the time (min) needed to reach the 50% of the
erythrocyte population that is lysed. The subscripts 𝑆 and 𝐶
stand for the antioxidant sample and the control, respectively.
2.1.2. 96-Well Plate Format. As described by Takebayashi’s
et al. work [30], the erythrocyte suspensions (50 𝜇L), in the
absence or presence of an antioxidant sample (100𝜇L) in
PBS, were added to a flat bottom 96-well plate. Complete
hemolysis was obtained by adding water to the erythrocyte
suspension without sample. The plate was preincubated with
a lid at 37∘C; then, AAPH (50 𝜇L, 160mM in PBS) was added
to initiate the assay and incubated at 37∘C in the incubator
with shaking. The optical density at 660 nm was measured
every 10min. The percentage of survival erythrocyte popu-
lation (P) was calculated as follows:
𝑃 = (
𝑛
𝑡
− 𝑛max
𝑛
0
− 𝑛max
) × 100, (2)
where 𝑛 is the optical density measure at the start of the
reaction (0) or at any t (min) and 𝑛max is themaximumoptical
density of the complete hemolysis. Then, the time to reach
50% of the survival population (𝜏) is obtained graphically for
an increasing concentration of an antioxidant. Afterwards,
(2) is used to normalize the 𝜏 values formulated by (1).
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2.1.3. Quantification. The kinetic part is solved in general
by a graphical method. In the test-tube and microplate
approaches, the Δt values obtained are analyzed in liner
terms as a function of the antioxidant concentration. The
slope ([A]/min) of such analysis is used as the comparative
value between different compounds. Although such a double
approach is correct, it seems contradictory that the algebraic
tools are reserved only to the second part of the procedure,
which prevents the statistical validation of the results as a
whole. The statistical information of the parameters found
in the first graphical step is lost, and even if we compute
the parametric estimations of the second step, it does not
take into account the variable involved in the first step. Thus,
among other problems, the two-step procedure lacks a proper
statistical estimation.
2.2. Data for Model Verification. The bibliographical abun-
dance about antioxidant activity in a competitive reaction, in
raw and purified extracts, makes it practically superfluous to
extend the experimental work, specifically devoted to validate
the model proposed here. In this respect, its descriptive
accuracy was verified using results from other authors (taken
from the published figures by means of GetData Graph
Digitizer 2.24), selected in such a way that they implied
different methods, substrates, and time domains. Table 1
shows a detailed description of the references used, the
corresponding figures subjected to analysis, the variable or
agent involved, and some relevant conditions of the assays. As
it will be noted, the studies fromwhich the data was collected
are those that had been involved in developing, reviewing,
or extending the methodology responses evaluated here. We
hope that the reader would find them as key data, rather than
a lack of experimental effort.
2.3. Numerical and Statistical Methods. Fitting the experi-
mental results to the proposed equations was carried out
in two phases. First, parametric estimates were obtained by
minimization of the sum of quadratic differences between
observed and model-predicted values, using the nonlinear
least-square (quasi-Newton) method provided by the macro
Solver in Microsoft Excel 2003, which allows quick testing
of hypotheses and the display of their consequences. Next,
the determination of the parametric confidence intervals
and model consistency (Student’s 𝑡-test and Fisher’s 𝐹-test,
respectively, in both cases with 𝛼 = 0.05) was calculated using
the “SolverAid” [33]. The “SolverStat” macro [34, 35] was
used for detecting possible anomalies in the distribution of
parametric estimates and residuals.
3. Results and Discussion
In general, the bioassay studied here is of a special elegance
and applicability. One of the major drawbacks is the lack of
formal model to describe the kinetic erythrocyte hemolysis.
Therefore, the quantification of the hemolytic time 𝜏 (time
to reach the 50% of the survival population of erythrocytes)
has to be obtained graphically or similarly from the kinetic
erythrocyte survival curve and thus, the results provided
lack of relevant statistical information. Additionally, such a
lack of mathematical expression causes low reproducibility
of results, which often leads to accumulation of procedural
restrictions that could overstandardize the protocol. Despite
the existence of very rigorous results about the kinetics and
the factors affecting the reproducibility of the method, for
some reasons, the quantification of the results has been left
as it was postulated originally [24].
Next, we will briefly review different mathematical
methodologies from related fields of study, such as the antiox-
idant, dose-response, and hemolytic bioassays. Afterwards,
based on such analysis, a simple illustrative bivariate (simul-
taneous analysis of time and effector responses)mathematical
application for many different effector agents that affect the
hemolytic process is presented. Then, a highly appropriated
alternative model for OxHLIA is verified by using data
from other authors that had investigated the capacity of
several antioxidants in the OxHLIA reactions. Finally, other
effectors that may obstruct or be of interest for antioxidant
determination are modeled in similar principles as those
defined in the OxHLIA reaction.
3.1. Modeling Approaches from Related Fields of Study.
Besides other authors [41–43], we reject the simplistic ways
of characterization of antioxidant action and we attempt to
address this issue by bringing across well-established ideas
from existing fields to overcome the existing problems for the
quantification OxHLIA antioxidant bioassay. Table 2 shows
a short review of different mathematical expressions from
related fields of study that provide the key knowledge to guide
the development of appropriate solution for the OxHLIA
antioxidant bioassay. At present, the reaction mechanism
of the erythrocyte lysis is well understood. Authors have
developed a sophisticated mechanistic model to evaluate the
erythrocyte lysis [39]. The detailed mechanistic description
of oxidation is complex because the heterogeneity of the cell
population varies from one to the other systems making it
difficult to characterize the responses and measure all the
compounds involved in the reaction. Therefore, researches
tend to search for empirical general models [28, 40], able to
quantify and evaluate the complex phenomenon of hemol-
ysis. In this regard, authors [38] have demonstrated the
suitability of the Weibull survival distribution connecting its
parameters to blood properties.
From the antioxidant field, due to the complexity of the
oxidative reactions, multiple number of simple calculation
procedures anddifferentmechanistic or empiric kineticmod-
els [41–43, 48] are routinely used to compute the inhibitory
responses of different agents. Among the available nonlin-
ear models, the power function developed by Terpinc and
Abramovič [42] is only appropriate to adjust fractional-order
kinetic profiles, but it fails in the description of first-order
processes or sigmoidal profiles. The Logistic and Weibull
equations, which have been transferred from microbiology
and pharmacology dose-response fields to describe the oxi-
dation action [41, 43], are more appropriate equations for
modeling oxidation processes.
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From the dose-response theory, the three-parameter
sigmoidal group of functions (such as the Logistic, Weibull,
Hill, Gompertz or Richards-Chapman) would be, in general,
acceptable solutions to fit individually the kinetic profiles
corresponding to a series of increasing level agents or
variables[44–47].
In general, most of the abovemodels can be transferred to
study the erythrocyte survival analysis found in the OxHLIA
method and help to compute, in a proper form, the inhibitory
features over the control curve produced by any antioxidant
agent.Thosemodels would be able to produce key parameters
to summarize the responses, such as the asymptote, half-life,
maximum velocity, or the lag-phase, and they can be used
to quantify the effect of different chemicals. However, in the
following, bymerging all the above solutions, wewill describe
in detail whatwe consider as suitable solution for theOxHLIA
antioxidant bioassay.
3.2. Mathematical Modeling for the Kinetic Description of
the Survival Erythrocyte Population
3.2.1. Normalization. In an open system, in the presence of
enough quantity of initiator (AAPH) and in the absence of an
antioxidant, the peroxidation of the erythrocyte membrane
would be oxidized exhaustively at sufficiently long times,
causing its rupture, producing asymptotic responses that
would correspond to the erythrocyte populationmixed in the
solution. Consequently, the spectrophotometric responses
(R) should be carefully standardized. Therefore, before the
data is analyzed, the response (R) must be normalized as
a function of the maximum hemolysis (𝑅max) that can be
achieved. For example, a simple way could be to compute the
𝑅 in terms of survival population (P) in percentage as follows:
𝑃 = (
𝑅
𝑅max
) × 100. (3)
Normalization of the raw data throughmultiplication adjusts
the resulting sample variation (human error, excessive or
defective dilution, number of red blood cells that are present,
and so forth). Fitting the normalized data resulted in a
significant increase in the reproducibility and accuracy of the
results obtained, but no significant change in the parameters
was produced.
3.2.2. Kinetic Description of the Survival Erythrocyte Pop-
ulation (Univariate Approach). The above previous works
[28, 38, 40] reflect as the most appropriate alternative the
use of sigmoidal profiles to describe the kinetic hemolysis of
erythrocytes. In accordance with other authors, we have also
found that the Weibull survival distribution [49] is a suitable
solution for the analysis of OxHLIA survival responses. The
function can be formulated in terms of the variables t (time)
and P (survival erythrocyte population) in its original form
as follows:
𝑃
100
= exp [−( 𝑡
𝑏
)
𝑎
] , (4)
where 𝑎 and 𝑏 are parameters of form and position, respec-
tively. Its use, in our context, requires two modifications: (1)
to multiply the second member by the maximum response
K, to assure that the asymptote can take values different from
100% in case any antioxidant or other variable may be able to
protect a partial erythrocyte population from hemolysis and
(2) to reparametrize the equation in such a way that it would
include explicitly the time for the substrate half-life (𝜏), which
is the desirable parameter in this type of bioassay. Therefore,
the time course of the survival population of erythrocytes can
be postulated to occur as function of the parameters variation
as in the following equation:
𝑃 = 𝐾 exp [− ln 2( 𝑡
𝜏
)
𝛼
] , (5)
where 𝐾 is the asymptote, 𝜏 is the time required for 50%
oxidation (substrate half-life), and 𝛼 is shape parameter
related to the maximum slope of the response. Equation (5)
is very versatile: when 𝛼 < 1, it can adjust the profiles of
potential responses; when 𝛼 = 1, a first-order kinetic is
described; when 𝛼 > 1, a variety of sigmoidal profiles are
produced.
3.2.3. Additional Parameters of Interest. Apart from the 𝜏
parameter, other interesting ones can be obtained, such as the
maximum rate of hemolysis (vm), the rate at the 𝜏 value (V𝜏),
and the lag-phase (𝜆). The rate values can be obtained with
some algebraic modifications from (5) as presented in Table 3
(part A). Regarding the appearance of a lag-phase, since no
induction period was observed inmicellemodel systems, this
feature of the profile in the OxHLIA survival responses is
attributed [50] to the action of antioxidants present in the
erythrocyte membrane. The confidence intervals of v
𝑚
, V
𝜏
,
and 𝜆 could be estimated by means of the reparameterization
of (5) to make such values explicit (Table 3, part A), but the
result is less operative than the robust estimation of the 𝜏
parameter [31].
3.2.4. Application to Bibliographic Antioxidant Data. Fig-
ure 1(a) shows the typical time-dose response of hemolysis
curves using the antioxidant trolox at various concentrations
0-(25)-125 𝜇M (dots). The results were obtained from the
study of Takebayashi et al. [26] (Case A1 in Table 1) who
recently published a detailed revision of the method. The
collected data was normalized by (3) and fitted (lines) to
the kinetic survival function (5). Parametric estimations are
shown in Table 4. Statistically significant results were found
continuously (Student’s t-test, 𝛼 = 0.05), the equation was
consistent (Fisher’s F-test), and the goodness of fit coefficient
of determination was higher than 0.98. Figures 1(b), 1(c),
and 1(d) show the pattern of the parametric responses as a
function of the antioxidant concentration. The parameters 𝜏
and 𝜆 show a linear behavior, while the rate parameters of V
𝜏
and vm display a decreasing asymptotic hyperbolic relation.
Any of those parameters can be easily described via simple
functions. Such a description produces detailed information,
summarized in parameters that can be used to compare the
AC of compounds, as an example.
Most of this information is already well-known [24, 30,
41]. However, authors [30, 32, 36] obtain the 𝜏 parameter, the
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Table 3: Part A shows the additional parameters of interest (V
𝑚
, V
𝜏
, and 𝜆) and reparameterization equations deduced from algebraic
modifications of (5) to make such values explicit and therefore to compute their confidence intervals. Part B shows four of the most common
effector perturbations (linear, hyperbolic, sigmoidal, and bell modifications) on the kinetic description of the survival erythrocyte population.
A: Additional parameters of interest
Parameter calculation Reparameterization form of (5) Eq. number
V
𝑚
=
𝐾𝛼 ln 2
𝜏
𝐺
𝐺
𝑒
−𝐺
𝑃 = 𝐾 exp[−(ln 2)1−𝛼(
𝑒
𝐺V
𝑚
𝑡
𝐾𝛼𝐺
𝐺
)
𝛼
] (i)
V
𝜏
=
𝐾𝛼 ln 2
2𝜏
𝑃 = 𝐾 exp [−(ln 2)1−𝛼(
2V
𝜏
𝑡
𝐾𝛼
)
𝛼
] (ii)
𝜆 =
𝜏
𝛼
√ln 2
[𝐺
1/𝛼
+
𝑒
−𝐺
− 1
𝛼𝐺
𝐺
𝑒
−𝐺
] 𝑃 = 𝐾 exp[−((𝐺1/𝛼 + 𝑒
−𝐺
− 1
𝛼𝐺
𝐺
𝑒
−𝐺
)
𝑡
𝜆
)
𝛼
] (iii)
B: effector variations on the survival population
Effector relation Model chosen to modify parameters of (5) Eq. no.
Linear (𝐿) 𝐿 (𝑒) = 𝑒 ⋅ 𝑙
1
+ 𝑙
2
(iv)
Hyperbolic (𝐻) 𝐻(𝑒) = ℎ
1
[1 − exp (ℎ
2
⋅ 𝑒)] (v)
Sigmoidal (𝑆) 𝑆 (𝑒) = 𝑠
1
exp [− ln 2(𝑒/𝑠
2
)
𝑠
3
] (vi)
Bell (𝐵) 𝐵 (𝑒) = 𝑏
1
{
𝑏
3
𝑏
2
[1 − (
𝑒
𝑏
4
)
𝑏
2
+ ln( 𝑒
𝑏
4
) 𝑏
2
]} (vii)
Part A: maximum rate of hemolysis (V𝑚); the rate at the value (V𝜏); the lag-phase (𝜆); and 𝐺 = (𝛼 − 1)/𝛼.
Part B: 𝑙1 is the slope (𝑡/𝑒 units); 𝑙2 is the intercept (𝑡 units); ℎ1 is the asymptotic value of the hyperbolic relation (parameter modified units); ℎ2 is 1/𝑒 units;𝑠1 is
the asymptotic value (parameter modified units) of the nonlinear relation, 𝑠2 is the IC50 value (𝑒 units); 𝑠3 is a shape parameter related to the maximum slope
of the response; 𝑏1 is the maximum value (parameter modified units), 𝑏2 is related to the distance between the tails of the function (𝑒 units), 𝑏3 is a value related
to the asymmetry of the bell profile, and 𝑏4 is the effector value at which 𝑏1 takes place (𝑒 units).
Table 4: Parametric estimations and statistic information of the kinetic series of the survival erythrocyte population inhibited by the
antioxidant trolox and fitted to the kinetic model (5).
Effector Kinetic parameters Statistics Reparameterization
Trolox (𝜇M) 𝐾(% Ert)
𝜏
(min) 𝛼 𝑅
2
adj
V
𝜏
(% Ert/min)
Vmax
(% Ert/min)
𝜆
(min)
0 100 ± 1.15 68.12 ± 10.03 4.59 ± 2.48 0.9992 2.34 ± 1.01 2.35 ± 0.88 39.92 ± 12.12
25 100 ± 1.15 86.05 ± 10.63 6.44 ± 5.17 0.9993 2.59 ± 0.98 2.63 ± 0.47 59.87 ± 17.22
50 100 ± 1.15 102.96 ± 10.74 8.26 ± 7.73 0.9984 2.78 ± 0.75 2.85 ± 0.65 78.16 ± 21.34
75 100 ± 1.15 117.26 ± 10.53 10.14 ± 6.89 0.9988 3.00 ± 0.68 3.09 ± 0.32 94.04 ± 18.75
100 100 ± 1.15 130.76 ± 10.47 11.20 ± 6.92 0.9987 2.97 ± 0.59 3.06 ± 0.89 107.22 ± 21.24
125 100 ± 1.15 144.26 ±10.60 10.86 ± 8.30 0.9971 2.61 ± 0.85 2.69 ± 0.97 117.51 ± 31.25
most consistent one, by graphical analysis, and then a linear
analysis is used to analyze the dose effect. Occasionally, (5) or
similar are used [37] to extract the relevant information from
the kinetic survival curve and then, the dose effect over the
𝜏 parameter is analyzed separately in linear terms. As it has
being done in Figure 1, the analysis is performed in a two-
step procedure. The statistical information of the parameters
found in the first step is lost in the second one. Even if we
compute the parametric estimations of the second step, it
does not take into account the variable involved in the first
step. Thus, among other problems, the two-step procedure
lacks a proper statistical estimation.
When the kinetic OxHLIA survival responses were
produced in the test-tube format, simple approaches seem
to be acceptable. However, since the development of the
microplate procedure, effortless time-dose data can be
obtained and more complex or robust solutions are rec-
ommended. Next, general alternatives, including those to
describe the antioxidant responses to build simultaneous
solutions for most typical modifications of the kinetic ery-
throcyte survival curve by common tested effectors, are
discussed.
3.3. Mathematical Model of Effectors Altering the Kinetic
Description of the Survival Erythrocyte Population. Thedevel-
opment of a theoretical model is greatly facilitated by the
possibility of combining all experimental data into a single
master curve that is able to account for the important
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Figure 1: Kinetics of the haemolytic oxidation at different antioxidant concentrations and relationships among the concentration of
antioxidant and the parameters that characterize its activity. (a) The kinetic series of the survival erythrocyte population fitted (lines) to
the kinetic model (5) using the antioxidant trolox at various concentrations 0-(25)-125𝜇M (dots). The results were obtained from the study
of Takebayashi et al. [26] (Case A1 in Table 1) who recently made a detailed revision of the method. Parametric estimations are showed in
Table 4. (b), (c), and (d) show the pattern of the parametric responses as a function of the antioxidant concentration. The parameters 𝜏 and
𝜆 show a linear behavior, while the rate is the modified final V
𝜏
and V
𝑚
displaying a decreasing asymptotic hyperbolic relation.
variables simultaneously. Such a solutions allows us to control
most factors that affect the system, helping to standardize
the key variables for producing reproducible protocols and
therefore, to obtain reproducible results.Despite the existence
of very rigorous results regarding the kinetics and the factors
affecting the kinetic curve of the survival erythrocyte pop-
ulation, simultaneous solutions are not always performed,
and by applying them, we can provide key knowledge to
understand partially the governing mechanisms.
3.3.1. Possible Effector Variations on the Kinetic Description
of the Survival Erythrocyte Population. We considered an
effector as a variable or chemical entity that can cause a shape
variation on the kinetic curve of the survival erythrocyte pop-
ulation, for example, the surfactant or NaCl concentration,
typically applied in the osmotic fragility test; environmental
variables such as pH and temperature; prooxidants such as
AAPH; antioxidant agents. Unfortunately, due to the diversity
and complexity of the perturbations of those effectors over
the survival erythrocyte population curve, it is complex to
postulate one empiric model that could be applied indiscrim-
inately to produce all corresponding shape variations. The
perturbations caused can be very different and affect one or
various parameters of (5) (or any other reparametrized form).
In general terms, four of the most common perturbations
(linear, hyperbolic, sigmoidal, and bell modifications) over
the kinetic curve of the erythrocyte survival population are
summarized in Table 3 (part B).
Those pattern descriptions suggest different mechanisms
of the cell lysis process. However, as in the previous section,
because of the heterogeneity of themechanistic reactions, it is
difficult to characterize in mechanistic terms the hemolysis.
Therefore, modeling with phenomenological approaches is
themost appropriate solution to consider.When the previous
phenomenologicalmodels are usedwe are not uncovering the
mechanistic relations, but the hemolytic responses are a com-
plex set of sequential and parallel reactions that represent, to
an extent, one of the phenomenological curves.
In this regard, linear variations over the parameter 𝜏
have been found when describing the antioxidant inhibitory
effects over the erythrocyte survival curve [24, 26, 30].
Hyperbolic ones have been found, when describing the effects
of prooxidant agents, such as AAPH [36]. Sigmoidal effects
also have been found, when describing the concentration of
the surfactant or agents such as NaCl or the toxic palytoxin
[28, 38, 40]. Bell profiles are normally found when analyzing
the effects of variables such as temperature or pH [28].
The reader should note that the equations available to
describeH, S, and𝐵 relations are diverse.Wehave selected the
ones that we felt appropriate, but many different ones could
be used.
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3.3.2. Simultaneous Solution to Describe the Effector Modi-
fications over the Kinetic Curve of the Survival Erythrocyte
Population: A Bivariate Approach. To introduce any of the
previous phenomenological effector functions (f ) affecting
the survival erythrocyte (5), but without altering the kinetic
parameters, such f should multiply any of its parameters (𝜃)
as follows:
𝑚
𝜃
= 𝜃
𝐶
× [1 + 𝑓 (𝑒)] ; where (𝜃 = 𝐾, 𝜏, 𝛼) , (6)
in which𝑚
𝜃
is the modified final function for the parameters
𝜃 present in (5). Thus, when any parameter 𝜃 is perturbed
by 𝑓(𝑒), it becomes also a function of the variable e, but its
original value without perturbation (or control, 𝜃
𝐶
) remains
intact, and so does its statistical information. Therefore, a
bivariate equation can be formulated, as a function of 𝑡
and the modifier e, increasing significantly the descriptive
capabilities of the model for real cases. In its more complete
case, the proposal would be as follows:
𝑃 (𝑡, 𝑒) = 𝑚
𝐾
exp [− ln 2( 𝑡
𝑚
𝜏
)
𝑚
𝛼
] . (7)
In consequence, when an entire set of kinetic profiles is
simultaneously described by (7), the term 𝑚
𝜃
typifies the
specific variation, characterized by the mechanism caused
due to the effector variable. Such a characterization allows
using one (in the case of L relation) or various parameters
(for H, S, or 𝐵 relations) of 𝑚
𝜃
and its statistical information
for different purposes. This multivariable characterization
is especially robust, minimizing the effects of random and
systematic errors. As stated by many authors before [44,
51], optimally and efficient data analysis should involve
simultaneous description of all curves, rather than fitting
each one individually.The simultaneous curve-fitting reduces
the number of parameters needed to analyze the response,
which is a more informative approach and provides better
estimations of parameters, andfinally reduces their interval of
confidence [31]. In addition, once all the modes of action are
mathematically known, if the experimental curves obtained
do not span the full range and some of them fail to provide
information about one or more of the parameters of the
equation, the bivariate application describes simply and
accurately all the responses.
The reader should note that we have selected (5) as the
principle model to perform the analysis of the effector agent.
Thus, we have selected the form that makes explicitly the 𝜏
parameter and avoided the other possible reparameterization
forms that provide other parameters of interests (vm, V𝜏,
and 𝜆). Such a preference, shared by many other authors in
many different fields, should not be a restriction.Those other
reparameterization forms could be used, but the essence of
the simultaneous approach should be kept.
In the following, the specific OxHLIA survival responses
produced by the action of antioxidant effectors are analyzed
in detail first, in which a simple simultaneous time-dose
model is presented. The model is verified using kinetic data
effects of dose response of several antioxidants collected from
the bibliography. Secondly, other typical modifications by
other effectors are described in bivariate terms, extending the
versatility and applicability of simultaneous approaches.
3.4. Verification of the Bivariate Procedure with Experimen-
tal Data from Bibliographic Results to Describe Antioxidant
Agents as Effectors. An oxidation inhibitor can be character-
ized in detail by the variations caused in the parameters of
(5), all of them with precise meanings, as well as theoretical
and practical interest with respect to the oxidation kinetics.
In open systems, the asymptotic parametric value (K) will
always reach the maximum oxidizable value (in this case the
100% of the erythrocyte population). Thus, as a function of
an A effector, the 𝐾 parameter should not be modified by its
action and should remain constant. Regarding the parameters
𝜏 and 𝛼, as suggested by the authors [24, 30], they should
be modified by L relation. Therefore, by inserting relation
((iv) Table 3) modifying the parameters 𝜏 and 𝛼 of (5), a
bivariate model is obtained, as a simultaneous function of
time and the modifier concentration. Figure 2 shows the
antioxidant (Table 1, Case A1) presented in Figure 1, analyzing
simultaneously the time and the dose. The statistical results
are displayed in part A of Table 5 (Case A1). From such deter-
mination, the parameter 𝑙
1
(min/𝜇Mof trolox),modifying the
𝜏 parameter of the kinetic curve of the survival erythrocyte
population, provides the key relevant information for AC
comparisons.
When we assume that the half-life (𝜏) is linearly modified
by the presence of an antioxidant, such a behavior translates
that each antioxidant molecule is able to capture the same
amount during the time of the assay, independently of the
type and the degree of polarity of the radicals generated.
Also, it implies that in solution the antioxidants stability
remains persistent during the time of the assay. This pattern
has been found in other kinetic responses from different
methodologies [41]. Figure 3 shows the analysis for other five
cases collected from literature data (A2–6, Table 1). As in the
previous case, the data could be modeled by inserting the
linear relation ((iv) Table 3) modifying the parameters 𝜏 and
𝛼 of (5). Parametric estimations and statistical information
of the fittings are found in Table 5. Linear variations are
successfully applied to the data published by different authors,
and when we simultaneously allowed nonlinear relations,
such as𝐻 or S, occasionally some improvements are obtained
(data not showed). However, this saturated effect was weak
and most of the attempts showed a nonsignificant solution
of at least one parameter. The nonlinear pattern descrip-
tions could uncover a saturated effect over the hemolytic
reaction. This saturated response behavior has been already
described in similar antioxidant responses by means of a
hyperbolic effect over one or several parameters of the
equation describing the kinetic oxidation, for example, the
responses described in the LDL [52], 𝛽-carotene [53], and
crocin [54] assay reactions to evaluate antioxidants. In any
case, the apparently consistent linearity of the responses
provides a simple solution to quantify the OxHLIA survival
responses (Figure 3 and Table 5).
3.5. Extending the Analysis to Other Effectors. It is known
that other effectors, such as metals, surfactants, and tem-
perature or light intensity, are harmful to cell membranes,
damaging its structure and eventually causing hemolysis.
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Table 5: Numeric results corresponding to the time-dose antioxidant responses collected from the bibliography (enumerated in Table 1)
adjusted to (7) perturbed by (iv) in Table 3.
Parametric estimates Statistics
Effector Kinetic parameters Effector modifying coefficients
𝑅
2
adj
𝐾 𝜏 𝛼 𝜏modifier (𝑙
1
) 𝛼modifier (𝑙
1
)
A1 Trolox 100.0 ± 0.5 70.5 ± 0.9 4.83 ± 6.9 0.0086 ± 2.2 0.0121 ± 16.5 0.9973
A2 Trolox 100.0 ± 0.3 84.2 ± 0.4 5.50 ± 3.6 0.0063 ± 1.4 0.0115 ± 9.7 0.9993
A3 Ascorbic Acid 100.0 ± 1.1 139.8 ± 1.8 4.97 ± 12.4 0.0032 ± 4.6 0.0030 ± 37.2 0.9937
A4 CazNH 100.0 ± 1.1 199.7 ± 1.3 5.03 ± 12.2 0.0470 ± 0.3 −0.0092 ± 11.9 0.9877
A5 IsbNH 100.0 ± 1.0 208.1 ± 1.4 5.07 ± 7.5 0.0356 ± 3.9 −0.0073 ± 46.8 0.9884
A6 DpaNH 100.0 ± 1.7 222.6 ± 1.8 6.48 ± 11.5 0.0798 ± 4.4 −0.0169 ± 47.8 0.9713
A7 PtzNH 100.0 ± 0.8 209.0 ± 1.2 6.65 ± 7.9 0.0184 ± 2.9 −0.0031 ± 47.4 0.9892
A8 PozNH 100.0 ± 0.9 186.5 ± 1.3 9.09 ± 11.3 0.1014 ± 2.6 −0.0295 ± 20.6 0.9890
Confidence intervals for 𝛼 = 0.05. 𝑅2adj: adjusted determination coefficient.
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Figure 2: Trolox antioxidant case (Case A1, Table 1), presented in Figure 1 and analyzed simultaneously in terms of time and the dose by
model (7). Statistical results in part A of Table 5 (Case A1).
Such effectors, such as the antioxidant concentration, are
dose-time dependent. Those effectors can be the interest in
the AC determination since they can also destabilize AC.
Understanding and describing its effect over the kinetic
erythrocyte population curve are crucial in order to be able
to quantify the changes that those effectors may produce.
More specifically, surfactants not only cause hemolysis,
but also are commonly used to help hydrosoluble compounds
to be solubilized in lipophilic environments or inversely.
In this sense, in the OxHLIA analysis, researches could be
interested to investigate how a hydrophilic A may be able to
penetrate beyond the surface of the erythrocyte membrane,
by adding different concentrations of a surfactant while
studying the time-dose effect of an A. We have not found any
bibliographic data available, but there are a plenty of studies
that deal with the hemolytic effect of surfactants. Therefore,
by being able to describe its effect in time- and effector-
dependent form, we are providing the basis for postulating
more complex multivariable models (time, antioxidant, and
surfactant dose effect). Also in the case of surfactants, other
agents or variables may be of interest to determine its effect
to provide the base for more intriguing effects over the AC
of compounds in the OxHLIA, such as the temperature or
prooxidant agents.
Although the modifications produced by other variables
(or effectors) over the kinetic erythrocyte population curve
have been studied in detail and in many diverse reactions,
this bibliographic data in many occasions is incomplete in
the variable range studied or the effect is mixed with other
variables. In addition, the data frequently is presented only
in a 3D graph, which makes its data digitization nearly
impossible. Thus, after an extensive search, only a small
quantity of available examples could be used to test the
general applicability of the general master model proposed.
Table 1 (part B) shows the examples selected. They involved
different effectors of different hemolytic assays, affecting the
kinetic survival erythrocyte population curve.
The results of applying kinetic model (5) or any of its
other reparameterization forms to the survival erythrocyte
population curve affected by different effectors varying one
or more parameters with one or various of the phenomeno-
logical functions described—Equations ((iv), (v), (vi), and
(vii) Table 3)—are presented in Figure 4 independently of the
mechanistic interpretation that can be inferred by analyzing
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Figure 3: Graphical representation of the time-dose antioxidant responses collected from the bibliography (enumerated in Table 1) adjusted
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Figure 4: Graphical results of applying the kinetic model (5) or any other reparameterization form to the survival erythrocyte population
curve affected by different effectors varying one or more parameters with one or various of the phenomenological functions described—
equations ((iv), (v), (vi), and (vii); Table 3).
the specific behavior of the characterizing parameters of (5)
andmodified by the actions of effectors.The time and effector
dependent functions are used, and this produces consistent
and meaningful criteria to characterize and quantify the
survival erythrocyte population minimizing the effects of the
error produced by the experimental conditions.
In this regard, when studying the activity of prooxidant
agent AAPH [36] (E1, Table 1) over the kinetic erythro-
cyte population curve (Figure 4(a)), 𝐻 decreasing behavior
affecting the parameter 𝜏 and 𝐿 increasing relation for the
parameter 𝛼 are found. Those phenomenological effector
responses over the erythrocyte population curve traduce a
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saturated effect produced by the AAPH agent. Figure 4(b)
shows a typical response in the osmotic fragility test caused
by the surfactant DATB [38] (E2, Table 1). The parametric
modifications over the parameters are inversely related to
those found for the previous case (𝐻 decreasing relation for
𝛼 and 𝐿 increasing one for 𝜏). When observing the isotonic
resistance test responses [39] (E3, Table 1), using increasing
concentrations of ammonium chloride (Figure 4(c)), 𝐿mod-
ifier relations are found for the parameters 𝜏 and 𝛼. Finally,
using the effect of temperature over kinetic erythrocyte
population curve [28], Figure 4(d) shows the case in which
a bell type curve is found useful to characterize the effector
pattern. For example, we have used the reparametrized form
(9), making explicitly the parameter that accounts for the
rate of the process when the 50% of the population are lysed
(V
𝜏
, % erythrocyte lysis/hr). The value V
𝜏
is modified by B
type function and the 𝛼 by L decreasing one. For all the
assayed effectors, statistically significant descriptions, with
very accurate predictions, were provided.
4. Conclusions
We have established that the kinetic model (5) (or any of
its other reparameterization forms) describes adequately the
variation of the degree of hemolysis as a function of the time.
Afterwards a simple bivariate analysis taking into account
the time and the antioxidant dose was successfully modeled
by means of a simultaneous analysis. Overall, in this paper,
a quantification method was developed for the OxHLIA
and verified by analyzing the results of other authors that
had investigated the capacity of several antioxidants. This
analysis reveals the high efficiency of the proposed approach.
The model parameters obtained were used to compare the
capacity, identify trends, and analyze the dose-equivalent sys-
tem response, providing more complete information about
antioxidant behavior.Therefore, amore efficient way to deter-
mine total antioxidant capacities than the simple approach to
study the dose-response in a two steps procedure is presented.
In addition, bivariate analysis taking into account the
time and other effectors was successfully modeled in similar
principles more than those used for antioxidant responses.
Using a bivariate model seems to be a disadvantage regarding
other apparent simpler routines. In agreement with the opin-
ion of Niki et al. [24], we believe that bivariate approaches
of the type proposed here could improve any bioassay in
which the inhibitory or stimulatory action of an effector
is superposed onto the variation with time of the target
system, or the particular time-course of the response is a
relevant aspect of that action. Most bioassays that are based
on hemolytic processes could be examples on this matter, as
it has been demonstrated and discussed above in detail.
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